[Clinical effect of cefpiramide against infectious diseases in obstetrics and gynecology].
Clinical study on cefpiramide (CPM, SM-1652), a new cephalosporin antibiotic, was carried out and the following results were obtained. CPM was intravenously administrated at a daily dose of 2 g to 8 cases including 2 cases with intrauterine infection, 3 cases with adnexitis, 2 cases with intrapelvic infection and 1 case with external genital infection. All cases responded to the drug, and marked response was seen in 2 cases, moderate response in 6 cases. Neither side effects nor abnormal values in clinical laboratory findings attributable to the drug were seen.
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy* / Q000517:prevention & control; D002511:Cephalosporins / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000150:complications; D005831:Genital Diseases, Female / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D011247:Pregnancy
D002511:Cephalosporins; C036666:cefpiramide